Cargando…
17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells
Heat Shock Factor 1 (HSF1) is a key regulator of gene expression during acute environmental stress that enables the cell survival, which is also involved in different cancer-related processes. A high level of HSF1 in estrogen receptor (ER)-positive breast cancer patients correlated with a worse prog...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826487/ https://www.ncbi.nlm.nih.gov/pubmed/31614463 http://dx.doi.org/10.3390/cancers11101533 |
_version_ | 1783465099459035136 |
---|---|
author | Vydra, Natalia Janus, Patryk Toma-Jonik, Agnieszka Stokowy, Tomasz Mrowiec, Katarzyna Korfanty, Joanna Długajczyk, Anna Wojtaś, Bartosz Gielniewski, Bartłomiej Widłak, Wiesława |
author_facet | Vydra, Natalia Janus, Patryk Toma-Jonik, Agnieszka Stokowy, Tomasz Mrowiec, Katarzyna Korfanty, Joanna Długajczyk, Anna Wojtaś, Bartosz Gielniewski, Bartłomiej Widłak, Wiesława |
author_sort | Vydra, Natalia |
collection | PubMed |
description | Heat Shock Factor 1 (HSF1) is a key regulator of gene expression during acute environmental stress that enables the cell survival, which is also involved in different cancer-related processes. A high level of HSF1 in estrogen receptor (ER)-positive breast cancer patients correlated with a worse prognosis. Here we demonstrated that 17β-estradiol (E2), as well as xenoestrogen bisphenol A and ERα agonist propyl pyrazole triol, led to HSF1 phosphorylation on S326 in ERα positive but not in ERα-negative mammary breast cancer cells. Furthermore, we showed that MAPK signaling (via MEK1/2) but not mTOR signaling was involved in E2/ERα-dependent activation of HSF1. E2activated HSF1 was transcriptionally potent and several genes essential for breast cancer cells growth and/or ERα action, including HSPB8, LHX4, PRKCE, WWC1, and GREB1, were activated by E2 in a HSF1-dependent manner. Our findings suggest a hypothetical positive feedback loop between E2/ERα and HSF1 signaling, which may support the growth of estrogen-dependent tumors. |
format | Online Article Text |
id | pubmed-6826487 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68264872019-11-18 17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells Vydra, Natalia Janus, Patryk Toma-Jonik, Agnieszka Stokowy, Tomasz Mrowiec, Katarzyna Korfanty, Joanna Długajczyk, Anna Wojtaś, Bartosz Gielniewski, Bartłomiej Widłak, Wiesława Cancers (Basel) Article Heat Shock Factor 1 (HSF1) is a key regulator of gene expression during acute environmental stress that enables the cell survival, which is also involved in different cancer-related processes. A high level of HSF1 in estrogen receptor (ER)-positive breast cancer patients correlated with a worse prognosis. Here we demonstrated that 17β-estradiol (E2), as well as xenoestrogen bisphenol A and ERα agonist propyl pyrazole triol, led to HSF1 phosphorylation on S326 in ERα positive but not in ERα-negative mammary breast cancer cells. Furthermore, we showed that MAPK signaling (via MEK1/2) but not mTOR signaling was involved in E2/ERα-dependent activation of HSF1. E2activated HSF1 was transcriptionally potent and several genes essential for breast cancer cells growth and/or ERα action, including HSPB8, LHX4, PRKCE, WWC1, and GREB1, were activated by E2 in a HSF1-dependent manner. Our findings suggest a hypothetical positive feedback loop between E2/ERα and HSF1 signaling, which may support the growth of estrogen-dependent tumors. MDPI 2019-10-11 /pmc/articles/PMC6826487/ /pubmed/31614463 http://dx.doi.org/10.3390/cancers11101533 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Vydra, Natalia Janus, Patryk Toma-Jonik, Agnieszka Stokowy, Tomasz Mrowiec, Katarzyna Korfanty, Joanna Długajczyk, Anna Wojtaś, Bartosz Gielniewski, Bartłomiej Widłak, Wiesława 17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells |
title | 17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells |
title_full | 17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells |
title_fullStr | 17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells |
title_full_unstemmed | 17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells |
title_short | 17β-Estradiol Activates HSF1 via MAPK Signaling in ERα-Positive Breast Cancer Cells |
title_sort | 17β-estradiol activates hsf1 via mapk signaling in erα-positive breast cancer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826487/ https://www.ncbi.nlm.nih.gov/pubmed/31614463 http://dx.doi.org/10.3390/cancers11101533 |
work_keys_str_mv | AT vydranatalia 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells AT januspatryk 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells AT tomajonikagnieszka 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells AT stokowytomasz 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells AT mrowieckatarzyna 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells AT korfantyjoanna 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells AT długajczykanna 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells AT wojtasbartosz 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells AT gielniewskibartłomiej 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells AT widłakwiesława 17bestradiolactivateshsf1viamapksignalinginerapositivebreastcancercells |